Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

ADA, Okla. (KTEN) — Ada City Manager Tracy Roles was placed on paid administrative leave during a special council meeting on Wednesday night. After more than three hours of discussion in ...

A drop below $0.69 support could extend losses, but reclaiming $0.77 resistance may trigger a push toward the $1.02 zone. promo Cardano (ADA) is facing renewed pressure, dropping nearly 5% on ...

Claims analysis included 27.3 million members with commercial insurance coverage. “Looking ahead, GLP-1 therapies will continue expanding beyond obesity and diabetes treatment to other chronic ...

The Department of Justice (DOJ) on Wednesday removed what it called “outdated” and “unnecessary” red tape for businesses to comply with the Americans with Disabilities Act (ADA).

New solution leverages Quantum Health’s clinical expertise, health coaching and holistic care coordination combined with Vida Health’s evidence-based prescribing to optimize GLP-1 utilization ...

All patients remained adherent to the GLP-1 medication through 8 months. "I believe combining the Allurion Balloon with low-dose GLP-1 therapy has several advantages," said Dr. Luigi Flagiello ...

Many employers are facing challenges in incorporating high-cost GLP-1 medications, such as Mounjaro, Ozempic, Rybelsus, Trulicity, and Wegovy, into their group health plans, as they must balance ...

The GLP-1 class of drugs used to treat diabetes and obesity may have the potential to benefit huge swaths of the public, but ongoing employer concerns over cost and a lack of patient adherence ...